THERAMetrics holding AG announces today its financial results for 2014 Montag, 13. April 2015 - 22:50

Stans, Switzerland, April 13, 2015

THERAMetrics holding AG (SIX: TMX) today published its financial results for the year 2014. 

THERAMetrics generated revenues of EUR 16.2 million and EBITDA of minus EUR 4.9 million for the year ended 31 December 2014, compared to revenues of EUR 16.9 million and EBITDA of minus EUR 7.8 million for the year ended 31 December 2013. 

The company incurred a net loss of EUR 10.2 million for the year ended 31 December 2014 compared to a net loss of EUR 10.0 million for the year ended 31 December 2013. Basic and diluted loss per share for the same periods was EUR 0.021 and EUR 0.058, respectively. 

The improvement in EBITDA is primarily the result of a decrease in administrative expenses resulting from continuing austerity measures. 

This improvement in EBITDA is offset by EUR 3.2 million of non-recurring impairment charges against goodwill. 

With austerity measures now executed and a more efficient corporate structure in place, the company’s turnaround efforts will be focused on revenue growth. Adding to its continued success in refilling the contract pipeline of the CRO business, the company has recently signed its first revenue-generating contracts for its DRR2.0 technology. Additionally, THERAMetrics continues to have success in the selling and licensing of its palette of internally developed medicinal product candidates The Company recently signed a licensing agreement for Aviptadil with Centurion Pharma in Turkey and is negotiating similar agreements with other pharma companies. 

The annual report 2014 is available here

About Therametrics holding AG
Therametrics holding AG is a global tech-based Contract Research & Development Organisation dedicated to providing a full range of technological solutions through the entire value chain of drug discovery and development. The company is listed on the SIX Swiss Exchange under the symbol TMX and is headquartered in Stans, Switzerland.

For further information please contact 
Raffaele Petrone
THERAMetrics holding AG
Investor and External Relations
T. +41 (0)44 723 59 59
F. +41 (0)44 726 90 12
investor@therametrics.com
www.therametrics.com

Media relation:
Press Area - Società & Servizi srl
mi@areacomunicazione.info

Disclaimer
This communication expressly or implicitly contains certain forward-looking statements concerning THERAMetrics holding AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of THERAMetrics holding AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. THERAMetrics holding AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

Files:

pdf eng